BACKCompositions for preserving biological fluid samples
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 23 February 2025]
We are inviting expressions of interest (EoI) for commercializing “Compositions for preserving biological fluid samples” technology. The innovation is developed by Professor LAI Hei Ming, Professor of Department of Chemical Pathology of The Chinese University of Hong Kong (CUHK Reference: 24/MED/1373).
The Technology
The collection of biological fluid samples such as blood and urine is non-invasive, the measurement of the analytes within which can provide invaluable to the ongoing healthy and diseased state from which the sample is collected from. The accuracy and costs of these tests lies in whether the analytes can be preserved upon collection, storage, and transport under various conditions, as the collection of the sample is usually different in space and time from the analysis of the sample. In this invention, we provide a general composition that can preserve a wide variety of analyte classes, including but not limited to small molecules, peptides, proteins, nucleic acids, carbohydrates, and lipids, ensuring stability and reproducibility of their compartmental concentration over the time course of storage for 14 days at room temperature. This enables cost-efficient tests and logistics to be developed for the analysis of these biolgoical fluid samples.
Commercialization
The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus.
This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and the University is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration.
Compositions for preserving biological fluid samples
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 23 February 2025]
We are inviting expressions of interest (EoI) for commercializing “Compositions for preserving biological fluid samples” technology. The innovation is developed by Professor LAI Hei Ming, Professor of Department of Chemical Pathology of The Chinese University of Hong Kong (CUHK Reference: 24/MED/1373).
The Technology
The collection of biological fluid samples such as blood and urine is non-invasive, the measurement of the analytes within which can provide invaluable to the ongoing healthy and diseased state from which the sample is collected from. The accuracy and costs of these tests lies in whether the analytes can be preserved upon collection, storage, and transport under various conditions, as the collection of the sample is usually different in space and time from the analysis of the sample. In this invention, we provide a general composition that can preserve a wide variety of analyte classes, including but not limited to small molecules, peptides, proteins, nucleic acids, carbohydrates, and lipids, ensuring stability and reproducibility of their compartmental concentration over the time course of storage for 14 days at room temperature. This enables cost-efficient tests and logistics to be developed for the analysis of these biolgoical fluid samples.
Commercialization
The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus.
This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and the University is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration.